The short version
- Why people research itMitochondrial and cellular-energy support, tissue-specific bioregulation and healthy-aging pathways.
- What the evidence isNo human trial of indole-3-propionamide exists, and no human pharmacokinetic study of it exists in any species.
- What to watchFlushing, hunger and a head-rush, which would suggest the vial holds ipamorelin.
How Indolepropionamide works
Get the two molecules straight first, because almost everything written about this product is written about the other one. Indole-3-propionic acid (IPA) is an indole ring carrying a three-carbon chain ending in a carboxylic acid: C11H11NO2.
That group is not a detail, it is the charge. A carboxylic acid with a pKa in the low single figures is essentially fully deprotonated at blood pH, so IPA circulates as an anion. A primary amide does not ionize in that range, so IPAM circulates neutral — and charge is what sets protein binding, passive membrane permeability and renal handling.
Indolepropionamide (IPAM, C11H12N2O, which removes the negative charge the acid carries at blood pH. The acid's published mechanism is radical chemistry — hydroxyl-radical scavenging that exceeded melatonin's in kinetic competition — plus ligand activity at the pregnane X receptor, which is a route to its gut-barrier effects. The amide's own paper argues something different: that it binds the rate-limiting component of oxidative phosphorylation in complex I of the mitochondrial respiratory chain and stabilizes energy metabolism, reducing ROS production by cutting electron leakage rather than by scavenging radicals. The assumption the whole product rests on — has never been measured.
- Oral
On the goal map: Mitochondrial & metabolic reprogramming (Lose fat)
Research on Indolepropionamide8 evidence notes: clinical, correlative, mechanism
Each note is labeled by the kind of evidence it stands on. Unproven is not ineffective: a missing trial means nobody has run it yet. How the evidence tiers work
Evidence on file: Theoretical — the amide's entire published record is one 2010 paper in isolated rodent mitochondria and rotifers, and no human study of indole-3-propionamide exists. The 15-year Finnish human data is an association and it belongs to the related acid, indole-3-propionic acid, not to this molecule.
Human clinical evidence
No human trial of indole-3-propionamide exists, and no human pharmacokinetic study of it exists in any species. Its entire published record as a substance is a single 2010 paper in isolated rodent mitochondria and in rotifers. Everything else sold under the IPAM name borrows the literature of a different molecule.
No completed human trialThe compound it is constantly confused with is not the acid — it is Ipamorelin, a growth-hormone secretagogue with no chemical or pharmacological relationship to this at all. The names differ by three letters and the molecules have nothing in common.
Correlative data
Indole-3-propionic ACID — the free acid, not the amide — is associated with markedly lower incident type-2 diabetes in the Finnish Diabetes Prevention Study, followed for 15 years, with the association replicated in two further cohorts. That is the strongest human evidence anywhere near this compound, and it is an association with a metabolite the body's own bacteria make, not a trial of anything anybody swallowed.
Serum levels of the acid track dietary fiber intake and gut microbiome composition. The obvious confound is the obvious one: a person with more of this metabolite is a person eating more fiber.
The acid is absent from germ-free animals and is produced by *Clostridium sporogenes* and relatives through a defined aromatic-amino-acid pathway — so an endogenous supply already exists and varies with the microbiome rather than with intake.
How the mechanism reads
The acid is a ligand at the pregnane X receptor and the aryl hydrocarbon receptor, which is the plausible route to the gut-barrier effects reported for it, and the mechanism a supplement would have to reproduce to matter.
MechanisticThe mechanism's own best paper argues against a daily capsule. Acute exposure raised maximal mitochondrial respiration by about 21%; chronic exposure lowered it by about 19%, reproduced in human hepatic and endothelial cells.
MechanisticOne LC-MS/MS draw would settle it, and until somebody runs it the entire case for buying the amide rather than eating fiber rests on an untested assumption.
Mechanistic
Sources
- Poeggeler B, Sambamurti K, Siedlak SL, Perry G, Smith MA, Pappolla MA. A novel endogenous indole protects rodent mitochondria and extends rotifer lifespan. PLoS One 2010;5(4):e10206 · PMID 20421998
- Chyan YJ, Poeggeler B, Omar RA, Chain DG, Frangione B, Ghiso J, Pappolla MA. Potent neuroprotective properties against the Alzheimer beta-amyloid by an endogenous melatonin-related indole structure, indole-3-propionic acid. Journal of Biological Chemistry 1999;274(31):21937-42 · PMID 10419516
- Jasiewicz B, Kozanecka-Okupnik W, Przygodzki M, Warzajtis B, Rychlewska U, Pospieszny T, Mrowczynska L. Synthesis, antioxidant and cytoprotective activity evaluation of C-3 substituted indole derivatives. Scientific Reports 2021;11(1):15425 · PMID 34326403
- Venkatesh M, Mukherjee S, Wang H, Li H, Sun K, Benechet AP, Qiu Z, Maher L, Redinbo MR, Phillips RS, Fleet JC, Kortagere S, Mukherjee P, Fasano A, Le Ven J, Nicholson JK, Dumas ME, Khanna KM, Mani S. Symbiotic bacterial metabolites regulate gastrointestinal barrier function via the xenobiotic sensor PXR and Toll-like receptor 4. Immunity 2014;41(2):296-310 · PMID 25065623
- Wikoff WR, Anfora AT, Liu J, Schultz PG, Lesley SA, Peters EC, Siuzdak G. Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. Proceedings of the National Academy of Sciences 2009;106(10):3698-703 · PMID 19234110
- Dodd D, Spitzer MH, Van Treuren W, Merrill BD, Hryckowian AJ, Higginbottom SK, Le A, Cowan TM, Nolan GP, Fischbach MA, Sonnenburg JL. A gut bacterial pathway metabolizes aromatic amino acids into nine circulating metabolites. Nature 2017;551(7682):648-652 · PMID 29168502
- de Mello VD, Paananen J, Lindstrom J, Lankinen MA, Shi L, Kuusisto J, Pihlajamaki J, Auriola S, Lehtonen M, Rolandsson O, Bergdahl IA, Nordin E, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, Landberg R, Eriksson JG, Tuomilehto J, Hanhineva K, Uusitupa M. Indolepropionic acid and novel lipid metabolites are associated with a lower risk of type 2 diabetes in the Finnish Diabetes Prevention Study. Scientific Reports 2017;7:46337 · PMID 28397877
- Sehgal R, de Mello VD, Mannisto V, Lindstrom J, Tuomilehto J, Pihlajamaki J, Uusitupa M. Indolepropionic acid, a gut bacteria-produced tryptophan metabolite and the risk of type 2 diabetes and non-alcoholic fatty liver disease. Nutrients 2022;14(21):4695 · PMID 36364957
- Koistinen VM, Haldar S, Tuomainen M, Lehtonen M, Klavus A, Draper J, Lloyd A, Beckmann M, Bal W, Ross AB, Brandt K, Fawcett L, Seal C, Hanhineva K. Metabolic changes in response to varying whole-grain wheat and rye intake. npj Science of Food 2024;8 · PMID 38291073
- Gesper M, Nonnast ABH, Kumowski N, Stoehr R, Schuett K, Marx N, Kappel BA. Gut-derived metabolite indole-3-propionic acid modulates mitochondrial function in cardiomyocytes and alters cardiac function. Frontiers in Medicine (Lausanne) 2021;8:648259 · PMID 33829028
- Wang G, Wu H, Wang Y, Liu X, Peng S, Wang W, Wu M, Liu Y, Wang E, Wang Z, Xu L, Wang X, Yang W, Chen H, Zhou X, Hou T. Discovery of novel Nav1.7-selective inhibitors with the 1H-indole-3-propionamide scaffold for effective pain relief. Research (Washington DC) 2025;8:0599 · PMID 39881860
Indolepropionamide safety basicsWho should avoid it, what to expect, what to watch
Avoid if
- Buying a product labeled IPAM without confirming it is not ipamorelin.
- Pregnancy or breastfeeding, where a synthetic indole amide has no record.
- Taking a tryptophan or serotonergic supplement alongside it.
- Under 18, where indole metabolites interact with developing gut flora.
What’s expected
- Antioxidant and neuroprotective effects shown in cells and rodents.
- Mild gut upset as an indole amide reaches the bowel.
- Different from the growth-hormone effect people expect from the name.
Watch for
- Flushing, hunger and a head-rush, which would suggest the vial holds ipamorelin.
- Itching or a rash that appears after the first capsules.
- Change in bowel habits.
Labs that tell you it’s working
- IGF-1: should NOT rise; a rise would mean the product is a growth-hormone secretagogue.
- hs-CRP: antioxidant and gut-barrier claims should show in inflammation.
- Comprehensive Metabolic Panel: baseline liver and kidney handling of a synthetic amide.
Amide analog of indole-3-propionic acid, a gut-bacterial tryptophan metabolite and mitochondrial protectant; not related to ipamorelin despite the shared abbreviation. PMID 20421998 PMID 10419516
Bloodwork to runHow you would know it is working: 8 tests in one order, code CAMERON
A panel picked from how it works and what it can move: the tests, and why each is on it.
Code CAMERON applies automatically. The before and after schedule and how to read the results are in the Skool lesson.
Indolepropionamide FAQ4 common questions
- Is Indolepropionamide approved for human use?
- No. Indolepropionamide is a research compound. No completed randomized human trial has given it yet.
- What is Indolepropionamide researched for?
- Mitochondrial and cellular-energy support, tissue-specific bioregulation and healthy-aging pathways.
- Which labs show whether it's doing anything?
- IGF-1; hs-CRP; Comprehensive Metabolic Panel: a baseline before you start and a recheck after. The panel on this page orders them in one cart.
- Where's the full protocol?
- In the Skool lesson for Indolepropionamide: the protocol, dose and schedule, timing, what to stack, the cycle answer, the bloodwork plan and the cheat sheet. Protocol & dosing live there, not on the public site.



